Abstract
Purpose
To evaluate the gonadal functions and related factors in female patients with acromegaly at the time of diagnosis, the course of gonadal dysfunctions and pregnancies during the follow-up period, and the investigation of ovarian reserve with serum anti-Mullerian hormone (AMH) levels in patients with reproductive age.
Methods
Patients who were not menopausal at the time of acromegaly diagnosis (n = 47) were included in this study. Baseline gonadal status was evaluated retrospectively. Patients were divided into three groups: normal gonadal function (group 1), gonadal dysfunction without central hypogonadism (group 2), and central hypogonadism (group 3). Group 1 and group 2 were compared in terms of clinical and laboratory findings. AMH levels were studied in patients who were ≤ 45 years old (n = 14) at the time of the study. Data related to pregnancies (n = 13) were evaluated retrospectively.
Results
Group 1 included 18 patients (38%), group 2 included 18 patients (38%), and group 3 included 11 patients (24%). The estimated duration of acromegaly was longer, and baseline PRL levels were higher, in group 2 than group 1 (p = 0.002 and p = 0.015, respectively). Gonadal functions recovered in 66% of patients. AMH levels were low in 64% of patients. The frequency of maternal diabetes and hypertension was 7.7%, and there was no tumoral growth in any of the pregnancies.
Conclusion
The most important factors affecting gonadal functions, excluding central hypogonadism, are hyperprolactinemia and the duration of the indolent period before diagnosis of acromegaly. AMH levels in the majority of patients were found to be lower than the expected age. Despite the decreased ovarian reserve, fertilization and normal birth can be achieved with careful surveillance.
Similar content being viewed by others
References
L. Katznelson, E.R. Laws Jr, S. Melmed, M.E. Molitch, M.H. Murad, A. Utz, J.A. Wass, Endocrine society, acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–3951 (2014)
S. Melmed, F.F. Casanueva, A. Klibanski, M.D. Bronstein, P. Chanson, S.W. Lamberts, C.J. Strasburger, J.A. Wass JA, A. Giustina, A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16(3), 294–302 (2013)
G.A. Kaltsas, J.J. Mukherjee, P.J. Jenkins, M.A. Satta, N. Islam, J.P. Monson, G.M. Besser, A.B. Grossman, Menstrual irregularity in women with acromegaly. J. Clin. Endocrinol. Metab. 84, 2731–2735 (1999)
J.D.N. Nabarro, Acromegaly. Clin. Endocrinol. (Oxf.). 26, 481–512 (1987)
M. Grynberg, S. Salenave, J. Young, P. Chanson, Female gonadal function before and after treatment of acromegaly. J. Clin. Endocrinol. Metab. 95(10), 4518–4525 (2010)
G.A. Kaltsas, I.I. Androulakis, K. Tziveriotis, D. Papadogias, A. Tsikini, P. Makras, K. Dimitriou, A. Stathopoulou, G. Piaditis, Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin. Endocrinol. (Oxf.). 67, 917–922 (2007)
L. Katznelson, D. Kleinberg, M.L. Vance, S. Stavrou, K.J. Pulaski, D.A. Schoenfeld, D.L. Hayden, M.E. Wright, C.J. Woodburn, A. Klibanski, Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clin. Endocrinol. (Oxf.). 54, 183–188 (2001)
A. Jadresic, L.M. Banks, D.F. Child, L. Diamant, F.H. Doyle, T.R. Fraser, G.F. Joplin, The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q. J. Med. 51, 189–204 (1982)
P. Caron, S. Broussaud, J. Bertherat, F. Borson-Chazot, T. Brue, C. Cortet-Rudelli, P. Chanson, Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J. Clin. Endocrinol. Metab. 95(10), 4680–4687 (2010)
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41–47 (2004)
D. Ferriman, J.D. Gallwey, Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21, 1440–1447 (1961).
A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed; Acromegaly Consensus Group, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95(7), 3141–3148 (2010)
E. Anckaert, M. Öktem, A. Thies, M. Cohen-Bacrie, N.M. Daan, J. Schiettecatte, C. Müller, D. Topcu, A. Gröning, F. Ternaux, C. Engel, S. Engelmann, C. Milczynski, Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determination. Clin. Biochem. 49(3), 260–267 (2016)
M.E. Molitch, Pathologic hyperprolactinemia. Endocrinol. Metab. Clin. North. Am. 21, 877–901 (1992)
R.V. Lloyd, M. Cano, W.F. Chandler, A.L. Barkan, E. Horvath, K. Kovacs, Human growth hormone and prolactin-secreting pituitary adenomas analyzed by in situ hybridization. Am. J. Pathol. 134, 605–613 (1989)
D.L. Kleinberg, J. Todd, Evidence that human growth hormone is a potent lactogen in primates. J. Clin. Endocrinol. Metab. 51, 1009–1013 (1980)
R. Abir, R. Garor, C. Felz, S. Nitke, H. Krissi, B. Fisch, Growth hormone and its receptor in human ovaries from fetuses and adults. Fertil. Steril. 90, 1333–1339 (2008)
S.S. Daftary, A.C. Gore, IGF-1 in the brain as a regulator of reproductive neuroendocrine function. Exp. Biol. Med. (Maywood). 230, 292–306 (2005)
V. Chandrashekar, D. Zaczek, A. Bartke, The consequences of altered somatotropic system on reproduction. Biol. Reprod. 71, 17–27 (2004)
H.D. Mason, H. Martikainen, R.W. Beard, V. Anyaoku, S. Franks, Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro. J. Endocrinol. 126, R1–R4 (1990)
R. Jirge PR, Ovarian reserve tests. J. Hum. Reprod. Sci. 4(3), 108–113 (2001)
A. de Vet, J.S. Laven, F.H. de Jong, A.P. Themmen, B.C. Fauser, Anti-Müllerian hormone serum levels: Aputative marker for ovarian aging. Fertil. Steril. 77, 357–362 (2002)
M. Karamouti, P. Kollia, A. Kallitsaris, N. Vamvakopoulos, G. Kollios, I.E. Messinis, Growth hormone, insulin-like growth factor I, and leptin interaction in human cultured lutein granulosa cells steroidogenesis. Fertil. Steril. 90, 1444–1450 (2008)
J.R. Silva, J.R. Figueiredo, R. van den Hurk, Involvement of growth hormone (GH) and insulin-like growth factor (IGF) system in ovarian folliculogenesis. Theriogenology 71(8), 1193–1208 (2009)
L. Poretsky, N.A. Cataldo, Z. Resenwaks, I.C. Giudice, The insulin-related ovarian regulatory system in health and disease. Endocrinol. Rev. 20, 535–582 (1999)
K. Kucuk, H. Kozinoglu, K. Ayten, Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J. Assist. Reprod. Genet. 25, 123–127 (2008)
J. Zhao, H.T.A. van Tol, M.A. Taverne, G.C. van deWeijden, M.M. Bevers, R. van den Hurk, The effect of growth hormone on rat preantral follicles in vitro. Zygote 3, 275–283 (2000)
A. Colao, B. Merola, D. Ferone, G. Lombardi, Acromegaly. J. Clin. Endocrinol. Metab. 82, 2777–2781 (1997)
R. Cozzi, R. Attanasio, M. Barausse, Pregnancy in acromegaly: a one-center experience. Eur. J. Endocrinol. 155, 279–284 (2006)
M. Dias, C. Boguszewski, M. Gadelha, L. Kasuki, N. Musolino, J. Vieira, J. Abucham, Acromegaly and pregnancy: a prospective study. Eur. J. Endocrinol. 170, 301–310 (2014)
A. Atmaca, S. Dagdelen, T. Erbas, Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp. Clin. Endocrinol. Diabetes 114, 135–139 (2006)
V. Herman-Bonert, M. Seliverstov, S. Melmed, Pregnancy in acromegaly: successful therapeutic outcome. J. Clin. Endocrinol. Metab. 83, 727–731 (1998)
S. Cheng, L. Grasso, J. Martinez-Orozco, R. Al-Agha, R. Pivonello, A. Colao, S. Ezzat, Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin. Endocrinol. (Oxf.). 76, 264–271 (2012)
A. Giustina, P. Chanson, D. Kleinberg, M.D. Bronstein, D.R. Clemmons, A. Klibanski, A.J. van der Lely, C.J. Strasburger, S.W. Lamberts, K.K. Ho, F.F. Casanueva, S. Melmed; Acromegaly Consensus Group, Expert consensus document: A consensus on the medical treatment of acromegaly. Nat. Rev. Endocrinol. 10(4), 243–248 (2014)
P. Maffei, G. Tamagno, G. Battista Nardelli, C. Videau, C. Menegazzo, G. Milan, A. Calcagno, C. Martini, R. Vettor, J. Epelbaum, N. Sicolo, Effects of octreotide exposure during pregnancy in acromegaly. Clin. Endocrinol. (Oxf.). 72, 668–677 (2010)
M. Ragonese, S. Grottoli, P. Maffei, A. Alibrandi, M.R. Ambrosio, G. Arnaldi, A. Bianchi, S. Puglisi, M.C. Zatelli, L. De Marinis, E. Ghigo, A. Giustina, F. Maffezzoni, C. Martini, L. Trementino, S. Cannavo, How to improve effectiveness of pegvisomant treatment in acromegalic patients. J. Endocrinol. Invest. https://doi.org/10.1007/s40618-017-0773-0
A. Giustina, G. Arnaldi, F. Bogazzi, S. Cannavò, A. Colao, L. De Marinis, E. De Menis, E. Degli Uberti, F. Giorgino, S. Grottoli, A.G. Lania, P. Maffei, R. Pivonello, E. Ghigo, Pegvisomant in acromegaly: an update. J. Endocrinol. Invest. 40(6), 577–589 (2017)
V. Herman-Bonert, S. Melmed. Pregnancy in acromegaly. in Pituitary Tumors in Pregnancy, ed. by M.D. Bronstein (Kluwer Academic Publishers, Norwell, MA, 2001) p. 109–121
O. Haliloglu, B. Dogangun, B. Ozcabi, H.U. Kural, F.E. Keskin, H.M. Ozkaya, F.C. Pamukcu, E. Bektas, B.C. Poyraz, H. Buber, O. Evliyaoglu, P. Kadioglu, General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers. Pituitary 19(4), 391–398 (2016)
S. Neslihan Carda, S.A. Bilge, T.N. Ozturk, G. Oya, O. Ece, B. Hamiyet, The menopausal age, related factors and climacteric symptoms in Turkish women. Maturitas 30, 37–40 (1998)
E.B. Gold, S.L. Crawford, N.E. Avis, C.J. Crandall, K.A. Matthews, L.E. Waetjen, J.S. Lee, R. Thurston, M. Vuga, S.D. Harlow, Factors related to age at natural menopause: longitudinal analyses from SWAN. Am. J. Epidemiol. 178(1), 70–83 (2013)
O. Cohen, B. Schindel, R. Homburg, Uterine leiomyomata-a feature of acromegaly. Hum. Reprod. 13(7), 1945–1946 (1998)
F.I. Sharara, L.K. Neiman, Growth hormone receptor messenger ribonucleotide acid expression in leiomyoma and surrounding myometrium. Am. J. Obstet. Gynecol. 172, 814–819 (1995)
L.C. Guidice, J.C. Irwin, B.A. Dsupin, Insulin like growth factor (IGF), IGF binding proteins (IGFBP) ang IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum. Reprod. 8, 1796–1806 (1993)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by the Ethics Committee of Istanbul University, Istanbul Faculty of Medicine.
Rights and permissions
About this article
Cite this article
Dogansen, S.C., Tanrikulu, S., Yalin, G.Y. et al. Female gonadal functions and ovarian reserve in patients with acromegaly: experience from a single tertiary center. Endocrine 60, 167–174 (2018). https://doi.org/10.1007/s12020-018-1540-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-018-1540-5